{"id":251211,"date":"2022-01-05T00:00:00","date_gmt":"2022-01-05T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidim0082-biopharma-male-lower-urinary-tract-symptoms-epidemiology-3\/"},"modified":"2026-03-31T10:41:11","modified_gmt":"2026-03-31T10:41:11","slug":"epidim0082-biopharma-male-lower-urinary-tract-symptoms-epidemiology-middle-east-africa","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidim0082-biopharma-male-lower-urinary-tract-symptoms-epidemiology-middle-east-africa\/","title":{"rendered":"Male Lower Urinary Tract Symptoms &#8211; Epidemiology &#8211; Middle East &#038; Africa"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of male lower urinary tract symptoms (<abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr>) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of male <abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, <abbr title=\"France, Germany, Italy, Spain, UK\">EU5<\/abbr>, and Japan and 10 years for the other countries covered in this report.<\/p>\n<p>Clarivate Epidemiology\u2019s male <abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all men with <abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr>, how many in each of the major mature pharmaceutical markets have been formally diagnosed?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of male <abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts nine male <abbr title=\"lower urinary tract symptoms\">LUTS<\/abbr> patient populations, as follows:<\/p>\n<ul class=\"round-bullets\">\n<li>Total prevalent cases.<\/li>\n<li>Mild prevalent cases.<\/li>\n<li>Moderate prevalent cases.<\/li>\n<li>Severe prevalent cases.<\/li>\n<li>Total prevalent cases with comorbid erectile dysfunction (<abbr title=\"erectile dysfunction\">ED<\/abbr>).<\/li>\n<li>Mild prevalent cases with comorbid <abbr title=\"erectile dysfunction\">ED<\/abbr>.<\/li>\n<li>Moderate prevalent cases with comorbid <abbr title=\"erectile dysfunction\">ED<\/abbr>.<\/li>\n<li>Severe prevalent cases with comorbid <abbr title=\"erectile dysfunction\">ED<\/abbr>.<\/li>\n<li>Diagnosed prevalent cases.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251211","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-male-lower-urinary-tract-symptoms","biopharma-product-epidemiology","biopharma-geography-middle-east-africa","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251211\/revisions"}],"predecessor-version":[{"id":576283,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251211\/revisions\/576283"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}